Small Cell Carcinoma of the Head and Neck: The University of Miami Experience

Georges F. Hatoum, Brandon Patton, Cristiane Takita, May Abdel-Wahab, Kelly LaFave, Donald Weed, Isildinha Reis

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Purpose: To describe the University of Miami experience in the treatment of small cell carcinoma of the head and neck. Methods and Materials: A total of 12 patients with nonmetastatic small cell carcinoma of the head and neck were treated between April 1987 and September 2007. Radiotherapy was the primary local treatment modality for 8 patients. Results: Of the 12 patients, 8 had died after a median follow-up of 13 months. The 4 patients who were alive were followed for a median of 14 months. The Kaplan-Meier estimate of the proportion of small cell head-and-neck cancer patients surviving to 1 and 2 years was 63% and 26%, respectively. The percentage of patients remaining disease free at 1 and 2 years was 71% and 44%, respectively. The patients with tonsil/parotid gland cancer had significantly greater disease-specific survival compared with the other patients. The median survival time was 30 months in the tonsil/parotid group compared with 15.2 months in the other group (patients with small cell carcinoma of the sinonasal cavity, nasopharynx, and larynx). A total of 4 patients developed recurrence, 3 of whom had a distant failure component. The treatment modality was not associated with a difference in disease-specific survival. The 1-year disease-specific survival rate was 73% in the radiotherapy or radiotherapy/chemotherapy group compared with 67% in the other group. Conclusion: Radiotherapy with or without chemotherapy is a reasonable alternative to surgery for patients with small cell carcinoma of the head and neck. Patients with tonsillar or parotid small cell carcinomas did better than other sites. More aggressive treatment might be warranted for patients with sinonasal carcinoma. The outcome, however, continues to be suboptimal, and more effective therapy is needed because most patients had a component of local and distant failure.

Original languageEnglish
Pages (from-to)477-481
Number of pages5
JournalInternational Journal of Radiation Oncology Biology Physics
Volume74
Issue number2
DOIs
StatePublished - Jun 1 2009

Fingerprint

Small Cell Carcinoma
Neck
cancer
Head
radiation therapy
Radiotherapy
Palatine Tonsil
chemotherapy
Survival
Parotid Neoplasms
larynx
salivary glands
Therapeutics
Drug Therapy
Nasopharynx
Parotid Gland
Kaplan-Meier Estimate
Head and Neck Neoplasms
Larynx
surgery

Keywords

  • Chemotherapy
  • Head and neck cancer
  • Radiotherapy
  • Small cell

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation
  • Cancer Research

Cite this

Small Cell Carcinoma of the Head and Neck : The University of Miami Experience. / Hatoum, Georges F.; Patton, Brandon; Takita, Cristiane; Abdel-Wahab, May; LaFave, Kelly; Weed, Donald; Reis, Isildinha.

In: International Journal of Radiation Oncology Biology Physics, Vol. 74, No. 2, 01.06.2009, p. 477-481.

Research output: Contribution to journalArticle

@article{826032944b35423786308508aa713422,
title = "Small Cell Carcinoma of the Head and Neck: The University of Miami Experience",
abstract = "Purpose: To describe the University of Miami experience in the treatment of small cell carcinoma of the head and neck. Methods and Materials: A total of 12 patients with nonmetastatic small cell carcinoma of the head and neck were treated between April 1987 and September 2007. Radiotherapy was the primary local treatment modality for 8 patients. Results: Of the 12 patients, 8 had died after a median follow-up of 13 months. The 4 patients who were alive were followed for a median of 14 months. The Kaplan-Meier estimate of the proportion of small cell head-and-neck cancer patients surviving to 1 and 2 years was 63{\%} and 26{\%}, respectively. The percentage of patients remaining disease free at 1 and 2 years was 71{\%} and 44{\%}, respectively. The patients with tonsil/parotid gland cancer had significantly greater disease-specific survival compared with the other patients. The median survival time was 30 months in the tonsil/parotid group compared with 15.2 months in the other group (patients with small cell carcinoma of the sinonasal cavity, nasopharynx, and larynx). A total of 4 patients developed recurrence, 3 of whom had a distant failure component. The treatment modality was not associated with a difference in disease-specific survival. The 1-year disease-specific survival rate was 73{\%} in the radiotherapy or radiotherapy/chemotherapy group compared with 67{\%} in the other group. Conclusion: Radiotherapy with or without chemotherapy is a reasonable alternative to surgery for patients with small cell carcinoma of the head and neck. Patients with tonsillar or parotid small cell carcinomas did better than other sites. More aggressive treatment might be warranted for patients with sinonasal carcinoma. The outcome, however, continues to be suboptimal, and more effective therapy is needed because most patients had a component of local and distant failure.",
keywords = "Chemotherapy, Head and neck cancer, Radiotherapy, Small cell",
author = "Hatoum, {Georges F.} and Brandon Patton and Cristiane Takita and May Abdel-Wahab and Kelly LaFave and Donald Weed and Isildinha Reis",
year = "2009",
month = "6",
day = "1",
doi = "10.1016/j.ijrobp.2008.08.014",
language = "English",
volume = "74",
pages = "477--481",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Small Cell Carcinoma of the Head and Neck

T2 - The University of Miami Experience

AU - Hatoum, Georges F.

AU - Patton, Brandon

AU - Takita, Cristiane

AU - Abdel-Wahab, May

AU - LaFave, Kelly

AU - Weed, Donald

AU - Reis, Isildinha

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Purpose: To describe the University of Miami experience in the treatment of small cell carcinoma of the head and neck. Methods and Materials: A total of 12 patients with nonmetastatic small cell carcinoma of the head and neck were treated between April 1987 and September 2007. Radiotherapy was the primary local treatment modality for 8 patients. Results: Of the 12 patients, 8 had died after a median follow-up of 13 months. The 4 patients who were alive were followed for a median of 14 months. The Kaplan-Meier estimate of the proportion of small cell head-and-neck cancer patients surviving to 1 and 2 years was 63% and 26%, respectively. The percentage of patients remaining disease free at 1 and 2 years was 71% and 44%, respectively. The patients with tonsil/parotid gland cancer had significantly greater disease-specific survival compared with the other patients. The median survival time was 30 months in the tonsil/parotid group compared with 15.2 months in the other group (patients with small cell carcinoma of the sinonasal cavity, nasopharynx, and larynx). A total of 4 patients developed recurrence, 3 of whom had a distant failure component. The treatment modality was not associated with a difference in disease-specific survival. The 1-year disease-specific survival rate was 73% in the radiotherapy or radiotherapy/chemotherapy group compared with 67% in the other group. Conclusion: Radiotherapy with or without chemotherapy is a reasonable alternative to surgery for patients with small cell carcinoma of the head and neck. Patients with tonsillar or parotid small cell carcinomas did better than other sites. More aggressive treatment might be warranted for patients with sinonasal carcinoma. The outcome, however, continues to be suboptimal, and more effective therapy is needed because most patients had a component of local and distant failure.

AB - Purpose: To describe the University of Miami experience in the treatment of small cell carcinoma of the head and neck. Methods and Materials: A total of 12 patients with nonmetastatic small cell carcinoma of the head and neck were treated between April 1987 and September 2007. Radiotherapy was the primary local treatment modality for 8 patients. Results: Of the 12 patients, 8 had died after a median follow-up of 13 months. The 4 patients who were alive were followed for a median of 14 months. The Kaplan-Meier estimate of the proportion of small cell head-and-neck cancer patients surviving to 1 and 2 years was 63% and 26%, respectively. The percentage of patients remaining disease free at 1 and 2 years was 71% and 44%, respectively. The patients with tonsil/parotid gland cancer had significantly greater disease-specific survival compared with the other patients. The median survival time was 30 months in the tonsil/parotid group compared with 15.2 months in the other group (patients with small cell carcinoma of the sinonasal cavity, nasopharynx, and larynx). A total of 4 patients developed recurrence, 3 of whom had a distant failure component. The treatment modality was not associated with a difference in disease-specific survival. The 1-year disease-specific survival rate was 73% in the radiotherapy or radiotherapy/chemotherapy group compared with 67% in the other group. Conclusion: Radiotherapy with or without chemotherapy is a reasonable alternative to surgery for patients with small cell carcinoma of the head and neck. Patients with tonsillar or parotid small cell carcinomas did better than other sites. More aggressive treatment might be warranted for patients with sinonasal carcinoma. The outcome, however, continues to be suboptimal, and more effective therapy is needed because most patients had a component of local and distant failure.

KW - Chemotherapy

KW - Head and neck cancer

KW - Radiotherapy

KW - Small cell

UR - http://www.scopus.com/inward/record.url?scp=67349161809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349161809&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2008.08.014

DO - 10.1016/j.ijrobp.2008.08.014

M3 - Article

C2 - 19004574

AN - SCOPUS:67349161809

VL - 74

SP - 477

EP - 481

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 2

ER -